{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "study": "pancreatic cancer",
                    "method": "immunohistochemistry",
                    "protein": "FXR",
                    "expression": "different levels",
                    "tissues": "cancerous and adjacent",
                    "statistical significance": "p < 0.05"
                },
                "measures": "[FXR expression in cancerous tissues, FXR expression in adjacent tissues]",
                "outcomes": "[88, 88]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "FXR expression in the cancerous tissues and the adjacent tissues",
                    "group": "Cancerous tissues",
                    "comparison to": "Adjacent tissues",
                    "expression level": "protein level",
                    "method": "immunohistochemistry",
                    "patients": "88",
                    "FXR positive": "54 (61.4%)",
                    "FXR negative": "34 (38.6%)",
                    "statistical significance": "P < 0.05"
                },
                "measures": "[FXR Positive, FXR Negative]",
                "outcomes": "[54 (61.4%), 34 (38.6%)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study": "pancreatic cancer",
                    "method": "immunohistochemistry",
                    "protein": "FXR",
                    "expression": "different levels",
                    "tissues": "cancerous and adjacent",
                    "statistical significance": "p < 0.05"
                },
                "measures": "[FXR expression in cancerous tissues, FXR expression in adjacent tissues]",
                "outcomes": "[88, 88]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "FXR expression in the cancerous tissues and the adjacent tissues",
                    "group": "Adjacent tissues",
                    "comparison to": "Cancerous tissues",
                    "expression level": "protein level",
                    "method": "immunohistochemistry",
                    "patients": "88",
                    "FXR positive": "27 (30.7%)",
                    "FXR negative": "61 (69.3%)",
                    "statistical significance": "P < 0.05"
                },
                "measures": "[FXR Positive, FXR Negative]",
                "outcomes": "[27 (30.7%), 61 (69.3%)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study": "pancreatic cancer",
                    "method": "immunohistochemistry",
                    "protein": "FXR",
                    "expression": "different levels",
                    "tissues": "cancerous and adjacent",
                    "statistical significance": "p < 0.05"
                },
                "measures": "[positive FXR expression in cancerous tissues, positive FXR expression in adjacent tissues]",
                "outcomes": "[54, 27]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "FXR expression in the cancerous tissues and the adjacent tissues",
                    "group": "Cancerous tissues",
                    "comparison to": "Adjacent tissues",
                    "expression level": "protein level",
                    "method": "immunohistochemistry",
                    "patients": "88",
                    "FXR positive": "54 (61.4%)",
                    "FXR negative": "34 (38.6%)",
                    "statistical significance": "P < 0.05"
                },
                "measures": "[FXR Positive, FXR Negative]",
                "outcomes": "[54 (61.4%), 34 (38.6%)]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study": "pancreatic cancer",
                    "method": "immunohistochemistry",
                    "protein": "FXR",
                    "expression": "different levels",
                    "tissues": "cancerous and adjacent",
                    "statistical significance": "p < 0.05"
                },
                "measures": "[negative FXR expression in cancerous tissues, negative FXR expression in adjacent tissues]",
                "outcomes": "[34, 61]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "FXR expression in the cancerous tissues and the adjacent tissues",
                    "group": "Adjacent tissues",
                    "comparison to": "Cancerous tissues",
                    "expression level": "protein level",
                    "method": "immunohistochemistry",
                    "patients": "88",
                    "FXR positive": "27 (30.7%)",
                    "FXR negative": "61 (69.3%)",
                    "statistical significance": "P < 0.05"
                },
                "measures": "[FXR Positive, FXR Negative]",
                "outcomes": "[27 (30.7%), 61 (69.3%)]"
            },
            "match": "yes"
        }
    ],
    "total_extracted_claims": 3,
    "total_ground_truth_claims": 2,
    "number_of_matches": 2
}